What is the current annual EBITDA of ABBV?

As of today, ABBV annual EBITDA is $29.05B

What is 1-year change in ABBV annual EBITDA?

ABBV annual EBITDA is up +16.16% year-over-year

What is 3-year change in ABBV annual EBITDA?

ABBV annual EBITDA is down -6.49% over the past 3 years

How far is ABBV annual EBITDA from its all-time high?

ABBV annual EBITDA is currently -6.49% below its historical high of $31.07B set on December 31, 2022

How does ABBV annual EBITDA rank versus sector peers?

ABBV annual EBITDA is higher than 99.73% of companies in Healthcare sector

When is ABBV next annual earnings release?

The next annual earnings release for ABBV is on February 3, 2027

What is the current quarterly EBITDA of ABBV?

As of today, ABBV quarterly EBITDA is $8.35B

What is ABBV quarterly EBITDA most recent change?

ABBV quarterly EBITDA was down -3.05% on September 30, 2026

What is 1-year change in ABBV quarterly EBITDA?

ABBV quarterly EBITDA is up +25.14% year-over-year

How far is ABBV quarterly EBITDA from its all-time high?

ABBV quarterly EBITDA is currently -3.05% below its historical high of $8.61B set on June 30, 2026

How does ABBV quarterly EBITDA rank versus sector peers?

ABBV quarterly EBITDA is higher than 99.71% of companies in Healthcare sector

When is ABBV next earnings release?

The next earnings release for ABBV is on February 3, 2027

What is the current TTM EBITDA of ABBV?

As of today, ABBV TTM EBITDA is $31.60B

What is ABBV TTM EBITDA most recent change?

ABBV TTM EBITDA was up +5.61% on September 30, 2026

What is 1-year change in ABBV TTM EBITDA?

ABBV TTM EBITDA is up +15.45% year-over-year

How far is ABBV TTM EBITDA from its all-time high?

ABBV TTM EBITDA is currently -0.55% below its historical high of $31.77B set on March 31, 2023

How does ABBV TTM EBITDA rank versus sector peers?

ABBV TTM EBITDA is higher than 99.81% of companies in Healthcare sector

When is ABBV next earnings release?

The next earnings release for ABBV is on February 3, 2027

AbbVie Inc. (ABBV) EBITDA History & Chart Since 2009

Annual EBITDA

$29.05B$4.04B+16.16%

December 31, 2025

Summary

Current Value: As of today, ABBV annual EBITDA is $29.05B, up +16.16% on December 31, 2025
Historical Performance: ABBV annual EBITDA is down -6.49% over the past 3 years, up +31.45% over the past 5 years
All-Time High Comparison: ABBV annual EBITDA is currently -6.49% below its historical high of $31.07B set on December 31, 2022
3-Year Low Comparison: ABBV annual EBITDA is +16.16% above its 3-year low of $25.01B reached on December 31, 2024
Sector Comparison: ABBV annual EBITDA is higher than 99.73% of companies in Healthcare sector

EBITDA Chart

beforeafter

Performance

ABBV Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBITDA	Dec 31, 25	$29.05B	+16.2%	-6.5%	+31.4%	+358.2%
Quarterly EBITDA	Sep 30, 26	$8.35B	+25.1%	+23.9%	+10.9%	+2086.2%
TTM EBITDA	Sep 30, 26	$31.60B	+15.4%	+5.6%	+14.8%	+811.4%
Price	Nov 13, 26	$295.03	+27.0%	+112.8%	+152.2%	–
PE Ratio	Nov 13, 26	50.78	-71.0%	+33.8%	+82.3%	–
Annual Revenue	Dec 31, 25	$61.16B	+8.6%	+5.3%	+33.5%	+291.1%
Annual EPS	Dec 31, 25	$2.36	-1.2%	-64.4%	-13.3%	-10.7%
Annual EBIT	Dec 31, 25	$21.21B	+27.6%	-6.1%	+35.7%	+311.4%
Annual Net Income	Dec 31, 25	$4.19B	-1.3%	-64.4%	-8.1%	+0.4%

EBITDA Highs

ABBV Annual EBITDA Highs Comparison
Period	High	Date	Current
3Y	$31.07B	N/A	-6.5%
5Y	$31.07B	Dec 31, 22	-6.5%
All	$31.07B	Dec 31, 22	-6.5%

EBITDA Lows

ABBV Annual EBITDA Lows Comparison
Period	Low	Date	Current
3Y	$25.01B	Dec 31, 24	+16.2%
5Y	$22.10B	N/A	+31.4%
All	$5.84B	Dec 31, 09	+397.4%

EBITDA History

Year	Value	Change
2025	$29.05B	+16.2%
2024	$25.01B	-6.6%
2023	$26.78B	-13.8%
2022	$31.07B	+9.9%
2021	$28.27B	+27.9%
2020	$22.10B	+38.7%
2019	$15.93B	+14.6%
2018	$13.90B	+15.2%
2017	$12.07B	+9.8%

Year	Value	Change
2016	$10.98B	+18.4%
2015	$9.28B	+35.8%
2014	$6.83B	-5.6%
2013	$7.24B	-7.3%
2012	$7.80B	+7.2%
2011	$7.28B	+14.8%
2010	$6.34B	+8.5%
2009	$5.84B	-

FAQ

What is the current annual EBITDA of ABBV?: As of today, ABBV annual EBITDA is $29.05B
What is 1-year change in ABBV annual EBITDA?: ABBV annual EBITDA is up +16.16% year-over-year
What is 3-year change in ABBV annual EBITDA?: ABBV annual EBITDA is down -6.49% over the past 3 years
How far is ABBV annual EBITDA from its all-time high?: ABBV annual EBITDA is currently -6.49% below its historical high of $31.07B set on December 31, 2022
How does ABBV annual EBITDA rank versus sector peers?: ABBV annual EBITDA is higher than 99.73% of companies in Healthcare sector
When is ABBV next annual earnings release?: The next annual earnings release for ABBV is on February 3, 2027

EBITDA Formula

EBITDA = Net Income + Interest Expense + Income Tax + D&A

Quarterly EBITDA

$8.35B$263.00M-3.05%

September 30, 2026

Summary

Current Value: As of today, ABBV quarterly EBITDA is $8.35B, down -3.05% on September 30, 2026
Historical Performance: ABBV quarterly EBITDA is up +25.14% year-over-year, up +23.89% over the past 3 years
All-Time High Comparison: ABBV quarterly EBITDA is currently -3.05% below its historical high of $8.61B set on June 30, 2026
3-Year Low Comparison: ABBV quarterly EBITDA is +64.88% above its 3-year low of $5.06B reached on March 31, 2024
Sector Comparison: ABBV quarterly EBITDA is higher than 99.71% of companies in Healthcare sector

Performance

ABBV Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBITDA	Sep 30, 26	$8.35B	-3.0%	+25.1%	+23.9%	+10.9%
Annual EBITDA	Dec 31, 25	$29.05B	–	+16.2%	-6.5%	+31.4%
TTM EBITDA	Sep 30, 26	$31.60B	+5.6%	+15.4%	+5.6%	+14.8%
Price	Nov 13, 26	$295.03	+17.6%	+27.0%	+112.8%	+152.2%
PE Ratio	Nov 13, 26	50.78	-28.4%	-71.0%	+33.8%	+82.3%
Quarterly Revenue	Sep 30, 26	$17.40B	+2.4%	+10.3%	+25.0%	+21.4%
Quarterly EPS	Sep 30, 26	$2.37	+16.7%	+2289.7%	+137.8%	+33.5%
Quarterly EBIT	Sep 30, 26	$6.48B	-3.5%	+41.6%	+42.7%	+19.9%
Quarterly Net Income	Sep 30, 26	$4.21B	+16.7%	+2263.5%	+137.7%	+33.2%

Quarterly EBITDA Highs

ABBV Quarterly EBITDA Highs Comparison
Period	High	Date	Current
1Y	$8.61B	Jun 30, 26	-3.0%
3Y	$8.61B	Jun 30, 26	-3.0%
5Y	$8.61B	Jun 30, 26	-3.0%
All	$8.61B	Jun 30, 26	-3.0%

Quarterly EBITDA Lows

ABBV Quarterly EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$6.67B	N/A	+25.1%
3Y	$5.06B	Mar 31, 24	+64.9%
5Y	$5.06B	Mar 31, 24	+64.9%
All	$381.85M	Sep 30, 11	+2086.2%

Quarterly EBITDA History

Month	Value	Change
Sep 2026	$8.35B	-3.1%
Jun 2026	$8.61B	+23.7%
Mar 2026	$6.96B	-9.3%
Dec 2025	$7.68B	+15.1%
Sep 2025	$6.67B	-15.4%
Jun 2025	$7.89B	+30.6%
Mar 2025	$6.04B	-10.9%
Dec 2024	$6.78B	+11.9%
Sep 2024	$6.05B	-14.5%
Jun 2024	$7.08B	+39.8%
Mar 2024	$5.06B	-29.0%
Dec 2023	$7.13B	+5.8%
Sep 2023	$6.74B	-4.3%
Jun 2023	$7.04B	-10.9%
Mar 2023	$7.90B	-4.2%
Dec 2022	$8.24B	+2.9%
Sep 2022	$8.01B	+5.2%
Jun 2022	$7.62B	+7.7%
Mar 2022	$7.07B	-3.0%
Dec 2021	$7.29B	-3.2%
Sep 2021	$7.53B	+10.3%
Jun 2021	$6.83B	+3.8%
Mar 2021	$6.58B	0.0%
Dec 2020	$6.58B	+13.2%
Sep 2020	$5.81B	+28.2%
Jun 2020	$4.53B	+8.5%
Mar 2020	$4.18B	+4.9%
Dec 2019	$3.98B	-4.2%
Sep 2019	$4.16B	+3.9%
Jun 2019	$4.00B	+5.4%
Mar 2019	$3.80B	+10.2%
Dec 2018	$3.44B	-7.6%

Month	Value	Change
Sep 2018	$3.73B	+14.5%
Jun 2018	$3.25B	-9.7%
Mar 2018	$3.60B	+26.3%
Dec 2017	$2.85B	-6.2%
Sep 2017	$3.04B	-2.7%
Jun 2017	$3.13B	+12.0%
Mar 2017	$2.79B	+1.6%
Dec 2016	$2.75B	-1.9%
Sep 2016	$2.80B	-0.6%
Jun 2016	$2.82B	+8.3%
Mar 2016	$2.60B	+6.2%
Dec 2015	$2.45B	+13.2%
Sep 2015	$2.17B	-11.3%
Jun 2015	$2.44B	+18.8%
Mar 2015	$2.05B	+25.6%
Dec 2014	$1.64B	0.0%
Sep 2014	$1.64B	-12.6%
Jun 2014	$1.87B	+13.9%
Mar 2014	$1.64B	-13.0%
Dec 2013	$1.89B	+0.1%
Sep 2013	$1.89B	+0.3%
Jun 2013	$1.88B	+19.6%
Mar 2013	$1.58B	-30.9%
Dec 2012	$2.28B	+11.4%
Sep 2012	$2.05B	+7.7%
Jun 2012	$1.90B	+21.6%
Mar 2012	$1.56B	-27.7%
Dec 2011	$2.16B	+465.6%
Sep 2011	$381.85M	-79.5%
Jun 2011	$1.86B	+51.6%
Mar 2011	$1.23B	-

FAQ

What is the current quarterly EBITDA of ABBV?: As of today, ABBV quarterly EBITDA is $8.35B
What is ABBV quarterly EBITDA most recent change?: ABBV quarterly EBITDA was down -3.05% on September 30, 2026
What is 1-year change in ABBV quarterly EBITDA?: ABBV quarterly EBITDA is up +25.14% year-over-year
How far is ABBV quarterly EBITDA from its all-time high?: ABBV quarterly EBITDA is currently -3.05% below its historical high of $8.61B set on June 30, 2026
How does ABBV quarterly EBITDA rank versus sector peers?: ABBV quarterly EBITDA is higher than 99.71% of companies in Healthcare sector
When is ABBV next earnings release?: The next earnings release for ABBV is on February 3, 2027

EBITDA Formula

EBITDA = Net Income + Interest Expense + Income Tax + D&A

TTM EBITDA

$31.60B$1.68B+5.61%

September 30, 2026

Summary

Current Value: As of today, ABBV TTM EBITDA is $31.60B, up +5.61% on September 30, 2026
Historical Performance: ABBV TTM EBITDA is up +15.45% year-over-year, up +5.58% over the past 3 years
All-Time High Comparison: ABBV TTM EBITDA is currently -0.55% below its historical high of $31.77B set on March 31, 2023
3-Year Low Comparison: ABBV TTM EBITDA is +26.54% above its 3-year low of $24.97B reached on December 31, 2024
Sector Comparison: ABBV TTM EBITDA is higher than 99.81% of companies in Healthcare sector

Performance

ABBV Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBITDA	Sep 30, 26	$31.60B	+5.6%	+15.4%	+5.6%	+14.8%
Annual EBITDA	Dec 31, 25	$29.05B	–	+16.2%	-6.5%	+31.4%
Quarterly EBITDA	Sep 30, 26	$8.35B	-3.0%	+25.1%	+23.9%	+10.9%
Price	Nov 13, 26	$295.03	+17.6%	+27.0%	+112.8%	+152.2%
PE Ratio	Nov 13, 26	50.78	-28.4%	-71.0%	+33.8%	+82.3%
TTM Revenue	Sep 30, 26	$66.01B	+2.5%	+10.7%	+19.7%	+19.7%
TTM EPS	Sep 30, 26	$5.81	+64.3%	+338.4%	+59.0%	+38.4%
TTM EBIT	Sep 30, 26	$23.91B	+8.7%	+25.5%	+13.0%	+26.5%
TTM Net Income	Sep 30, 26	$10.30B	+64.2%	+337.5%	+58.8%	+38.0%

TTM EBITDA Highs

ABBV TTM EBITDA Highs Comparison
Period	High	Date	Current
1Y	$31.60B	Sep 30, 26	at high
3Y	$31.60B	Sep 30, 26	at high
5Y	$31.77B	Mar 31, 23	-0.6%
All	$31.77B	Mar 31, 23	-0.6%

TTM EBITDA Lows

ABBV TTM EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$27.37B	N/A	+15.4%
3Y	$24.97B	Dec 31, 24	+26.5%
5Y	$24.97B	Dec 31, 24	+26.5%
All	$1.23B	Mar 31, 11	+2477.3%

TTM EBITDA History

Month	Value	Change
Sep 2026	$31.60B	+5.6%
Jun 2026	$29.92B	+2.5%
Mar 2026	$29.19B	+3.3%
Dec 2025	$28.27B	+3.3%
Sep 2025	$27.37B	+2.3%
Jun 2025	$26.75B	+3.1%
Mar 2025	$25.94B	+3.9%
Dec 2024	$24.97B	-1.4%
Sep 2024	$25.33B	-2.6%
Jun 2024	$26.01B	+0.1%
Mar 2024	$25.97B	-9.8%
Dec 2023	$28.81B	-3.7%
Sep 2023	$29.92B	-4.1%
Jun 2023	$31.20B	-1.8%
Mar 2023	$31.77B	+2.7%
Dec 2022	$30.94B	+3.2%
Sep 2022	$29.99B	+1.6%
Jun 2022	$29.51B	+2.7%
Mar 2022	$28.72B	+1.8%
Dec 2021	$28.23B	+2.6%
Sep 2021	$27.51B	+6.7%
Jun 2021	$25.79B	+9.8%
Mar 2021	$23.50B	+11.4%
Dec 2020	$21.10B	+14.0%
Sep 2020	$18.50B	+9.8%
Jun 2020	$16.85B	+3.3%
Mar 2020	$16.32B	+2.4%
Dec 2019	$15.93B	+3.5%
Sep 2019	$15.39B	+2.9%
Jun 2019	$14.96B	+5.3%
Mar 2019	$14.22B	+1.4%
Dec 2018	$14.02B	+4.4%

Month	Value	Change
Sep 2018	$13.43B	+5.4%
Jun 2018	$12.75B	+1.0%
Mar 2018	$12.62B	+6.8%
Dec 2017	$11.81B	+0.9%
Sep 2017	$11.71B	+2.1%
Jun 2017	$11.47B	+2.8%
Mar 2017	$11.16B	+1.7%
Dec 2016	$10.97B	+2.8%
Sep 2016	$10.67B	+6.3%
Jun 2016	$10.04B	+3.9%
Mar 2016	$9.66B	+6.0%
Dec 2015	$9.11B	+9.8%
Sep 2015	$8.30B	+6.8%
Jun 2015	$7.77B	+7.9%
Mar 2015	$7.20B	+6.0%
Dec 2014	$6.79B	-3.6%
Sep 2014	$7.04B	-3.5%
Jun 2014	$7.30B	-0.2%
Mar 2014	$7.31B	+1.0%
Dec 2013	$7.24B	-5.1%
Sep 2013	$7.63B	-2.0%
Jun 2013	$7.79B	-0.2%
Mar 2013	$7.80B	+0.2%
Dec 2012	$7.79B	+1.6%
Sep 2012	$7.67B	+27.7%
Jun 2012	$6.00B	+0.7%
Mar 2012	$5.96B	+6.0%
Dec 2011	$5.63B	+62.3%
Sep 2011	$3.47B	+12.4%
Jun 2011	$3.08B	+151.6%
Mar 2011	$1.23B	-

FAQ

What is the current TTM EBITDA of ABBV?: As of today, ABBV TTM EBITDA is $31.60B
What is ABBV TTM EBITDA most recent change?: ABBV TTM EBITDA was up +5.61% on September 30, 2026
What is 1-year change in ABBV TTM EBITDA?: ABBV TTM EBITDA is up +15.45% year-over-year
How far is ABBV TTM EBITDA from its all-time high?: ABBV TTM EBITDA is currently -0.55% below its historical high of $31.77B set on March 31, 2023
How does ABBV TTM EBITDA rank versus sector peers?: ABBV TTM EBITDA is higher than 99.81% of companies in Healthcare sector
When is ABBV next earnings release?: The next earnings release for ABBV is on February 3, 2027

EBITDA Formula

EBITDA = Net Income + Interest Expense + Income Tax + D&A

Data Sources & References

ABBV Official Website www.abbvie.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1551152/000155115226000008/0001551152-26-000008-index.htm
ABBV Profile on Yahoo Finance finance.yahoo.com/quote/ABBV
ABBV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/abbv